IGC Pharma, Inc. - Director's Dealing 2016

SEC Form 5 — Annual Statement of Changes in Beneficial Ownership

Issuer: India Globalization Capital, Inc. (IGC)
CIK: 0001326205
Period of Report: 2016-03-31

Reporting Person: PRINS RICHARD K (Director)

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2015-10-30	Common stock	G	2000	—	Disposed	234000	Direct
2015-11-06	Common stock	G	2000	—	Disposed	232000	Direct
2015-11-13	Common stock	G	2000	—	Disposed	230000	Direct
2015-11-20	Common stock	G	2000	—	Disposed	228000	Direct
2015-11-27	Common stock	G	2000	—	Disposed	226000	Direct
2015-12-04	Common stock	G	2000	—	Disposed	224000	Direct
2015-12-11	Common stock	G	2000	—	Disposed	222000	Direct
2015-12-18	Common stock	G	2000	—	Disposed	220000	Direct
2015-12-28	Common stock	G	2000	—	Disposed	218000	Direct
2016-01-08	Common stock	G	2000	—	Disposed	216000	Direct
2016-01-15	Common stock	G	2000	—	Disposed	214000	Direct
2016-01-22	Common stock	G	2000	—	Disposed	212000	Direct
2016-01-29	Common stock	G	2000	—	Disposed	210000	Direct
2016-02-05	Common stock	G	2000	—	Disposed	208000	Direct
2016-02-12	Common stock	G	2000	—	Disposed	206000	Direct
2016-02-19	Common stock	G	2000	—	Disposed	204000	Direct
2016-02-26	Common stock	G	2000	—	Disposed	202000	Direct
2016-03-07	Common stock	G	2000	—	Disposed	200000	Direct
2016-03-11	Common stock	G	2000	—	Disposed	198000	Direct
2016-03-18	Common stock	G	2000	—	Disposed	196000	Direct
2016-03-29	Common stock	G	2000	—	Disposed	194000	Direct
2016-03-31	Common stock	A	125000	—	Disposed	319000	Direct

F1: Represents shares of Common Stock awarded pursuant to the Issuer's 2008 Omnibus Incentive Plan.